1. Home
  2. LSBK vs CTMX Comparison

LSBK vs CTMX Comparison

Compare LSBK & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lake Shore Bancorp Inc.

LSBK

Lake Shore Bancorp Inc.

N/A

Current Price

$15.01

Market Cap

110.0M

Sector

Finance

ML Signal

N/A

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.18

Market Cap

596.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSBK
CTMX
Founded
1891
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
110.0M
596.2M
IPO Year
2006
2015

Fundamental Metrics

Financial Performance
Metric
LSBK
CTMX
Price
$15.01
$4.18
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$6.50
AVG Volume (30 Days)
17.4K
2.1M
Earning Date
01-23-2026
11-06-2025
Dividend Yield
2.39%
N/A
EPS Growth
105.28
50.22
EPS
1.21
0.24
Revenue
$27,774,000.00
$113,631,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.47
$17.49
Revenue Growth
9.61
N/A
52 Week Low
$11.50
$0.40
52 Week High
$16.95
$4.62

Technical Indicators

Market Signals
Indicator
LSBK
CTMX
Relative Strength Index (RSI) 64.19 57.94
Support Level $14.82 $3.78
Resistance Level $15.19 $4.25
Average True Range (ATR) 0.24 0.23
MACD -0.01 -0.00
Stochastic Oscillator 81.63 79.85

Price Performance

Historical Comparison
LSBK
CTMX

About LSBK Lake Shore Bancorp Inc.

Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: